Where does Deepa Pakianathan work?

Deepa Pakianathan is General Partner at Delphi Ventures and Board director at Calithera Biosciences.

What does Deepa Pakianathan invest in?

Deepa Pakianathan invests in Biotech, Healthtech, Medical Devices.

What check size does Deepa Pakianathan write?

Deepa Pakianathan typically writes checks of $50K – $5M.

Where did Deepa Pakianathan go to school?

Deepa Pakianathan studied at Wake Forest University (Doctor of Philosophy - PhD, Immunology and Immunoparasitology); Wake Forest University (Master of Science - MS, Immunology).

Deepa Pakianathan

Investor

General Partner at Delphi Ventures · Board director at Calithera Biosciences

San Francisco Bay Area

Writes $50K – $5M checks

Find your path to Deepa

289 people in our graph can introduce you to Deepa.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Doug Roeder to introduce you to Deepa

You →Doug · together at Delphi Ventures (2001–2026) →Deepa

Ask Jamie Chen to introduce you to Deepa

You →Jamie · together at Karyopharm Therapeutics Inc. →Deepa

Ask Sam Okafor to introduce you to Deepa

You →Sam · 9 people · together at Genentech →Deepa

Your email: the people you already email who know Deepa
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Deepa
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Deepa Pakianathan leads all biotech investing while serving as CEO and founder of a stealth oncology company, combining active operator experience, recognized expertise in immuno-oncology ADC design, and high-level policy engagement.

Invests in

BiotechHealthtechMedical Devices

Board director at Calithera Biosciences

Intro paths

→

In turn, Deepa can intro founders to Calithera Biosciences's investors below.

Calithera Biosciences's investors · 3

Longwood FundBoston · since 2014 The Column GroupSan Francisco · $30M checks · since 2010 Venture Capital Investment ManagementSan Francisco · since 2014

Co-founders at Calithera Biosciences

Susan M. MolineauxExecutive Officer, Director

Experience

Stealth Oncology CompanyCEO and co-foundercurrent2023 — present
FreenomeIndependent board membercurrent2021 — present
Delphi VenturesGeneral Partnercurrent2001 — presentSan Francisco Bay Area
Palleon PharmaceuticalsLead Director and Independent board membercurrent2020 — present
Theravance Biopharma US, Inc.Independent Board Membercurrent2020 — presentCommittees: Chair of N&G, Member of Audit and Development and Commercialization
Karyopharm Therapeutics Inc.Independent Board Membercurrent2011 — presentCommittees: Chair of Compensation and member of Audit and Development and Commercialization
Mereo BioPharmaIndependent Board Membercurrent2019 — presentChair of Audit and member of Remuneration committee
Calithera BiosciencesLead Director and Independent Board Member2010 — 2023Lead director, Chair of N&G
J.P. MorganVice President1998 — 2001
Genesis Merchant Group SecuritiesResearch Analyst1997 — 1998San Francisco Bay Area
GenentechPost-doctoral scientist1993 — 1997SSF, CA

Skills & more

Business StrategyMergers & AcquisitionsVenture CapitalEntrepreneurshipInvestment BankingLife Sciences1Biotechnology1Biotech investor1Public biotech Company board director

From Deepa's professional profile.

Colleagues at Delphi Ventures

Doug Roeder

General Partner at Delphi Ventures

Drew Henderson

Partner at Delphi Ventures

Tom Shaughnessy

Founding Partner at Delphi Ventures

Frequently asked questions

Who is Deepa Pakianathan?: Deepa Pakianathan leads all biotech investing while serving as CEO and founder of a stealth oncology company, combining active operator experience, recognized expertise in immuno-oncology ADC design, and high-level policy engagement.
Where does Deepa Pakianathan work?: Deepa Pakianathan is General Partner at Delphi Ventures and Board director at Calithera Biosciences.
What does Deepa Pakianathan invest in?: Deepa Pakianathan invests in Biotech, Healthtech, Medical Devices.
What check size does Deepa Pakianathan write?: Deepa Pakianathan typically writes checks of $50K – $5M.
Where did Deepa Pakianathan go to school?: Deepa Pakianathan studied at Wake Forest University (Doctor of Philosophy - PhD, Immunology and Immunoparasitology); Wake Forest University (Master of Science - MS, Immunology).

Same school

Also attended Wake Forest University180

Daniel van der MerweSenior Director at JMI Equity Nash Carey-EwendSenior Associate, Echo Health Advisors at Echo Health Ventures Andrew McGuirkVenture Fellow at Moneta Ventures Eliza CushmanPartner at Congruent Ventures Brett BrohlManaging Partner at Bread And Butter Ventures, Llc Jeff BaldwinPrincipal at TCV

+ 174 more

Shared employers

Also worked at Palleon Pharmaceuticals6

Katarina PancePrincipal at SR One Capital Management Nikola TrbovicManaging Partner at SV Health Investors Lori HuManaging Director at Vertex Ventures HC Dr. Jens EcksteinAdvisor at Apollo Health Ventures Ross LeimbergFounder / EIR at 82VS David FeltquateAdvisor at RA Capital

Also worked at Karyopharm Therapeutics Inc.7

Ari ShamissCo-Founder, Managing General Partner at ALIVE Israel HealthTech Fund Anat Haas MizrahiManaging Partner at E44 Ventures Sharon ShachamManaging Partner at E44 Ventures Stuart PoultonExecutive Officer at Karyopharm Reshma RangwalaExecutive Officer at Karyopharm Richard PaulsonExecutive Officer, Director at Karyopharm

+ 1 more

Also worked at Calithera Biosciences3

Sumita RayExecutive Officer at Cue Biopharma Susan M. MolineauxExecutive Officer, Director at Calithera Biosciences William WaddillExecutive Officer at Calithera Biosciences

Also worked at J.P. Morgan1,554

Cat WuInvestor at Index Ventures Rishi ModiInvestor at GV (Google Ventures)Akshat GoenkaInvestor at Moonfire Ventures Naseem MoumeneVice President at Northzone, investing across complex and fragmented industries undergoing fundamental shifts Franklin BiGeneral Partner at Pantera Capital Megan LightcapPartner, Creator Fund at Slow Ventures

+ 1,548 more